Shengyuan Peptides

Catalog / GH Axis Peptides / CJC-1295 NO DAC + Ipamorelin

CJC-1295 NO DAC + Ipamorelin research peptide — GH Axis Peptides

CJC-1295 NO DAC + Ipamorelin

Research blend of modified GRF(1–29) and the ghrelin-receptor agonist ipamorelin for combined growth hormone secretagogue studies.

CAS NumberN/A
Molecular Weight4079.8 Da
Purity99.3% (HPLC / MS verified)
CategoryGH Axis Peptides
Quality metricsHPLC purity, peptide content, and identity are reported separately on the batch COA — see the purity guide.
StorageStore the lyophilized blend at -20°C in a dry, light-protected container; keep sealed between uses to preserve ratio integrity.
Research use only. Not for human or veterinary use. We do not provide dosing guidance or medical advice.
Request a Quote View Batch COA Data

About CJC-1295 NO DAC + Ipamorelin

This blend combines CJC-1295 NO DAC (modified GRF 1–29), a GHRH-receptor agonist, with ipamorelin, a ghrelin-receptor (GHS-R1a) agonist. The two peptides stimulate growth hormone release through complementary receptor mechanisms: GHRH-receptor activation primes somatotrophs, while ghrelin-receptor signaling adds a parallel secretagogue input, a combination commonly studied for additive effects on growth hormone output and downstream IGF-1 responses. Researchers use this fixed-ratio blend to simplify formulation logistics in long-term preclinical protocols and to examine synergy between the two pathways. Blend quality requires more than individual peptide purity: accurate stoichiometry, absence of cross-contamination, and physical compatibility after lyophilization all affect reproducibility. Shandong Shengyuan prepares the blend from individually certified components, confirms component identity and ratio by LC-MS, and reports 99.3% combined RP-HPLC purity or higher. The lyophilized product is provided for research use only and is not intended for human or veterinary use.

Research Applications

  • Combined GHS-R1a and GHRH assays
  • GH synergy studies
  • Longitudinal IGF-1 research
  • Secretagogue pathway crosstalk
  • Preclinical GH axis protocols

Quality & Documentation

Every batch of CJC-1295 NO DAC + Ipamorelin is manufactured under our documented quality system and released with a Certificate of Analysis covering HPLC purity, mass spectrometry identity, peptide content, water content, and endotoxin. The batch code on your vial can be verified online in the COA lookup section of this site.

Related Products

Tesamorelin Tesamorelin Growth hormone-releasing factor analogue used to investigate pituitary GH secretion, IGF-1 axis signaling, and related metabolic endpoints in research models. Sermorelin Acetate Sermorelin Acetate Synthetic GHRH(1–29) analogue for investigating pituitary growth hormone release and GH/IGF-1 axis regulation in preclinical research. Ipamorelin Ipamorelin Selective growth hormone secretagogue pentapeptide for studying ghrelin-receptor signaling and GH release without pronounced effects on other pituitary hormones.